Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Anand, Uma ^a   Otto, William R ^a   Anand, Praveen ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 HYDROXYPHENYL) 4 (3 NITROPHENYL) 1,2,3,6 TETRAHYDROPYRIMIDIN 2 ONE; CALCIUM; CANNABINOID 2 RECEPTOR AGONIST; CAPSAICIN; CYCLIC AMP; GW 833972; NEUROMODULIN; OXALIPLATIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR AGONIST; WS 12; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX; PYRIMIDINONE DERIVATIVE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM8 PROTEIN, RAT;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; CELL FUNCTION; CELL STRUCTURE; CHRONIC TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SENSITIZATION; FEMALE; NERVE FIBER GROWTH; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL DETECTION; SPINAL GANGLION; ANIMAL; CELL CULTURE; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; NERVE CELL; TOXICITY AND INTOXICATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CAPSAICIN; CELLS, CULTURED; CYCLIC AMP; DRUG INTERACTIONS; NEURONS; NEUROTOXICITY SYNDROMES; ORGANOPLATINUM COMPOUNDS; PYRIMIDINONES; RATS; SENSORY SYSTEM AGENTS; TRPM CATION CHANNELS;

EID: 78549266497     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-6-82     Document Type: Article

References (77)

1. Anand U. Mechanisms and Management of cancer pain. The Cancer Handbook 2007, Chapter 98. Publishers John Wiley and Sons Ltd. Chichester, Alison MR, 2.
2. Portenoy RK. Difficult pain problems: an integrated approach. Oxford Textbook of Palliative medicine 2003, 438-458. Oxford University Press, New York, Doyle D, et al.
3. Peters L, Sellick K. Quality of life of cancer patients receiving in-patient and home-based palliative care. Journal of advanced nursing 2006, 53(5):524-533. 10.1111/j.1365-2648.2006.03754.x, 16499673.
4. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Periph Nerv Syst 2008, 13(1):27-46.
5. Cata JP, Weng HR, Lee BN, Reuben JM, Dougherty PM. Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anaestesiologica 2006, 72(3):151-169.
6. Chaudhry V, Cornblath DR, Polydefkis M, Ferguson A, Borrello I. Characteristics of bortezomib- and thalidomide- induced peripheral neuropathy. JPeriph Nerv Sys 2008, 13:275-282.
7. McWhinney SR, Goldberg RM, McLeod HL. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther 2009, 8(1):10-16. 10.1158/1535-7163.MCT-08-0840, 2651829, 19139108.
8. Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR. Taxol-induced sensory disturbance is characterised by preferential impairment of myelinated fibre function in cancer patients. Pain 2004, 109(1-2):132-142. 10.1016/j.pain.2004.01.021, 15082135.
9. Verstappen CC, Postma TJ, Hoekman K, Heimans JJ. Peripheral neuropathy due to therapy with paclitaxel, gemcitabine and cisplatin in patients with advanced ovarian cancer. Journal of Neuro-Oncology 2003, 63(2):201-205. 10.1023/A:1023952106955, 12825825.
10. Jacobson SC, Alberts SR, Goldberg RM. Oxaliplatin in the treatment of Colorectal cancer. Colorectal Cancer: Multimodality Management 2002, Chapter 29:525-872. Humana Press, Totowa, NJ, USA, Leonard B Saltz.
11. Cersosimo RJ. Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 2005, 39(1):128-35.
12. Krishnan AV, Goldstein D, Friedlander M, Kiernan MC. Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle nerve 2005, 32(1):51-60. 10.1002/mus.20340, 15880395.
13. Park SB, Goldstein D, Lin CS-Y, Krishnan AV, Friedlander ML. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 2009, 27(8):1243-1249. 10.1200/JCO.2008.19.3425, 19164207.
14. Park SB, Lin CSY, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain 2009, 132:2712-2723. 10.1093/brain/awp219, 19745023.
15. Attal N, Bouhassira D, Gautron M, Vaillant JN, Mitry E, Lepere C, Rougier P, Guirimand F. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain 2009, 144(3):245-52. 10.1016/j.pain.2009.03.024, 19457614.
16. Argyriou AA, Koltzenburg M, Polychronopoulos P, Papapetropoulous P, Kalofonos HP. Peripheral nerve damage associated with administration of taxanes in patients with cancer. Clin Reviews Oncol Haem 2008, 66:218-228.
17. Kaley TJ, DeAngelis LM. Therapy of chemotherapy-induced neuropathy. Brit J Haemat 2009, 145:3-14. 10.1111/j.1365-2141.2008.07558.x, 19170681.
18. Stucky CL, Dubin AE, Jeske NA, Malin SA, McKemy DD, Story GM. Roles of transient receptor potential channels in pain. Brain Res Rev 2009, 60(1):2-24. 10.1016/j.brainresrev.2008.12.018, 2683630, 19203589.
19. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824. 10.1038/39807, 9349813.
20. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000, 97:6155-6160. 10.1073/pnas.97.11.6155, 18574, 10823958.
21. Cesare P, McNaughton PA. A novel heat-activated current in nociceptive neurons, and its sensitization by bradykinin. Proc Natl Acad Sci USA 1996, 93:15435-15439. 10.1073/pnas.93.26.15435, 26422, 8986829.
22. Gharat L, Szallasi A. Medicinal chemistry of the vanilloid (Capsaicin) TRPV1 receptor: Current knowledge and future perspectives. Drug Dev Res 2007, 68:477-497.
23. Bennett DL, Koltzenburg M, Priestly JV, Shelton DL, McMahon SB. Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat. Eur J Neurosci 1998, 10(4):1282-1291. 10.1046/j.1460-9568.1998.00139.x, 9749782.
24. Winter J, Forbes CA, Sternberg J, Lindsay RM. Nerve growth factor regulates adult rat cultured dorsal root ganglion neuron responses to the excitotoxin capsaicin. Neuron 1988, 1(10):973-981. 10.1016/0896-6273(88)90154-7, 3272159.
25. Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. The EMBO Journal 2005, 24:421-4223.
26. Amaya F, Shimosato G, Nagano M, Ueda M, Hashimoto S, Tanaka Y, Suzuki H, Tanaka M. NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia. Eur J Neurosci 2004, 29(9):2303-2310.
27. Anand U, Otto WR, Casula MA, Day NC, Davis JB, Bountra C, Birch R, Anand P. The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurons. Neurosci Lett 2006, 399:51-56. 10.1016/j.neulet.2006.01.046, 16481104.
28. Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 2004, 146:477-492. full_text, 14699981.
29. Bar KJ, Saldanha GJ, Kennedy AJ, Facer P, Birch R, Carlstedt T, Anand P. GDNF and its receptor component Ret in injured human nerves and dorsal root ganglia. Neuroreport 1998, 9(1):43-47. 10.1097/00001756-199801050-00009, 9592045.
30. Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 1992, 35:351-355. 10.1002/art.1780350315, 1536673.
31. Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997, 79:572-577.
32. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994, 62:327-331. 10.1016/0306-4522(94)90366-2, 7530342.
33. Chan CL, Facer P, Davis JB, Yiangou Y, Dyer HN, Anand P. Sensory nerve fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and fecal urgency. Lancet 2003, 361:385-391. 10.1016/S0140-6736(03)12392-6, 12573376.
34. Facer P, Casula MA, Smith GD, Benham CD, Chessell IP, Bountra C, Sinisi M, Birch R, Anand P. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol 2007, 7:11. 10.1186/1471-2377-7-11, 1892784, 17521436.
35. Yiangou Y, Facer P, Dyer NH, Fowler C, Anand P. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001, 357:1338-1339. 10.1016/S0140-6736(00)04503-7, 11343743.
36. Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, Early A, Patapoutian A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004, 41:849-857. 10.1016/S0896-6273(04)00150-3, 15046718.
37. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, Earley TJ, Hergarden AC, Andersson DA, Hwang SW, McIntyre P, Jegla T, Bevan S, Patatoutian A. ANKTM1, a TRP-like channel expressed in nociceptive neurons is activated by cold temperatures. Cell 2003, 112:819-829. 10.1016/S0092-8674(03)00158-2, 12654248.
38. Jordt SE, Bautista DM, Chuang H, McKemy DD, Zygmunt PM, Hogestatt ED, Meng ID, Julius D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 2004, 427:260-265. 10.1038/nature02282, 14712238.
39. Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J, Yamoah EN, Basbaum AI, Julius D. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006, 124(6):1269-82. 10.1016/j.cell.2006.02.023, 16564016.
40. Zurborg S, Yurgionas B, Jira JA, Caspani O, Heppenstall PA. Direct activation of the ion channel TRPA1 by Ca2+. Nature Neuroscience 2007, 10(3):277-279. 10.1038/nn1843, 17259981.
41. Caspani O, Heppenstall PA. TRPA1 and cold transduction: An unresolved issue?. J Gen Physiol 2009, 133(3):245-249. 10.1085/jgp.200810136, 2654088, 19237589.
42. Knowlton WM, Bifolck-Fischer A, Bautista DM, McKemy DD. TRPM8, but not TRPA1 is required for neural and behavioural responses to acute noxious cold temperatures, and cold-mimetics in vivo. Pain 2010, 150(2):340-350. 10.1016/j.pain.2010.05.021, 20542379.
43. Bautista DM, Movahed P, Hinman A, Axelsson HE, Sterner O, Hogestatt E, Julius D, Jordt SE, Zygmunt PM. Pungent products from garlic activate the sensory ion channel TRPA1. PNAS 2005, 102(34):12248-12252. 10.1073/pnas.0505356102, 1189336, 16103371.
44. Anand U, Otto WR, Facer P, Zebda N, Selmer I, Gunthorpe MJ, Chessell IP, Sinisi M, Birch R, Anand P. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons. Neurosci Lett 2008, 438(2):221-227. 10.1016/j.neulet.2008.04.007, 18456404.
45. McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002, 416:52-58. 10.1038/nature719, 11882888.
46. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, Early TJ, Dragoni I, McIntyre P, Bevan S, Patapoutian A. A TRP channel that senses cold stimuli and menthol. Cell 2002, 108:705-715. 10.1016/S0092-8674(02)00652-9, 11893340.
47. Kuhn FJP, Kuhn C, Luckhoff A. Inhibition of TRPM8 by icilin distinct from desensitization induced by menthol and menthol derivatives. J Biol Chem 2009, 284(7):4102-4111. 10.1074/jbc.M806651200, 19095656.
48. Ta LE, Espeset L, Podratz J, Windebank AJ. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicity 2006, 27:992-1002.
49. Adelsberger H, Quasthoff S, Grosskreutz J, Lepier J, Eckel F, Lersch C. The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons. Eur J Pharmacol 2000, 406:25-32. 10.1016/S0014-2999(00)00667-1, 11011028.
50. Kagiava A, Tsingotjidou A, Emmanouilides C, Theophilidis G. The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat. Neurotoxicology 2008, 29:1100-1106. 10.1016/j.neuro.2008.09.005, 18845186.
51. Meiri KF, Pfeninger KH, Willard MB. Growth-associated protein GAP-43, a polypeptide that is induced when neurons extend axons is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci USA 1986, 83:3537-3541. 10.1073/pnas.83.10.3537, 323552, 3517863.
52. Aigner L, Caroni P. Depletion of 43-kd Growth-associated protein in primary sensory neurons leads to diminished formation and spreading of growth cones. J Cell Biol 1993, 123(2):417-429. 10.1083/jcb.123.2.417, 2119839, 8408223.
53. Hol EM, Mandys V, Sodaar P, Gispen WH, Bar PR. Protection by an ACTH4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro. J Neurosci Res 1994, 39:178-185. 10.1002/jnr.490390208, 7837287.
54. Melli G, Taiana M, Camozzi F, Triolo D, Podini P, Quattrini A, Taroni F, Lauria G. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol 2008, 214:276-284. 10.1016/j.expneurol.2008.08.013, 18809400.
55. Ta LE, Low PA, Windebank AJ. Mice with cisplatin and oxaliplatin -induced painful neuropathy develop distinct early responses to thermal stimuli. Mol Pain 2009, 5:9. 10.1186/1744-8069-5-9, 2655284, 19245717.
56. Wall PD, Devor M. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain 1983, 17(4):321-339. 10.1016/0304-3959(83)90164-1, 6664680.
57. Graham MA, Lockwood GF, Greenslade D, Brienza S, Bayssas M, Gamelin E. Clinical pharmacokinetics of oxaliplatin: a critical review. Clin Cancer Res 2000, 6:1205-1218.
58. Xiao WH, Bennett GJ. Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fibre and C-fibre primary afferent neurons and its suppression by acetyl-N-carnitine. Pain 2008, 135(3):262-70. 10.1016/j.pain.2007.06.001, 2689385, 17659836.
59. Zhang J, Tuckett RP. Comparison of Paclitaxel and Cisplatin effects on the slowly adapting type 1 mechanoreceptor. Brain Res 2008, 1214:50-57. 10.1016/j.brainres.2008.01.069, 18466884.
60. Ta LE, Bieber AJ, Carlton SM, Loprinzi CM, Low PA, Windebank AJ. Transient receptor potential vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Mol Pain 2010, 6:15. 10.1186/1744-8069-6-15, 2848188, 20205720.
61. Docherty RJ, Yeats JC, Bevan S, Boddeke HW. Inhibition of calcineurin inhibits the desensitization of capsaicin- evoked currents in cultured dorsal root ganglion neurones from adult rats. Pflugers Arch 1996, 431:828-837.
62. Koplas PA, Rosenberg RL, Oxford GS. The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons. J Neurosci 1997, 17:3525-3537.
63. Bhave G, Hu HJ, Glauner KS, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc Natl Acad Sci USA 2003, 100:12480-12485. 10.1073/pnas.2032100100, 218783, 14523239.
64. Anand U, Otto WR, Sanchez-Herrera D, Facer P, Yiangou Y, Korchev Y, Birch R, Benham C, Bountra C, Chessell IP, Anand P. Cannabinoid receptor CB2 localisation and agonist mediated inhibition of capsaicin responses in human sensory neurons. Pain 2008, 138(3):667-680. Epub Aug 9, 10.1016/j.pain.2008.06.007, 18692962.
65. Anand U, Otto WR, Bountra C, Chessell I, Sinisi M, Birch R, Anand P. Cytosine Arabinoside affects the heat and capsaicin receptor TRPV1 localisation and sensitivity in human sensory neurons. J NeuroOncol 2008, 89(1):1-7. 10.1007/s11060-008-9585-6, 18414789.
66. Morenilla-Palao C, Planells-Cases R, Garcia-Sanz N, Ferrer-Montiel A. Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 2004, 279(24):25665-25672. 10.1074/jbc.M311515200, 15066994.
67. Van Buren JJ, Bhat S, Rotello R, Pauza ME, Premkumar LS. Sensitization and translocation of TRPV1 by insulin and IGF-1. Mol Pain 2005, 1:17. 10.1186/1744-8069-1-17, 1142339, 15857517.
68. Taiwo YO, Bjerknes LK, Goetzl EJ, Levine JD. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience 1989, 32(3):577-580. 10.1016/0306-4522(89)90280-7, 2557557.
69. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002, 35:721-731. 10.1016/S0896-6273(02)00802-4, 12194871.
70. Sagar DR, Kelly S, Millns PJ, O'Shaughnessey CT, Kendall DA, Chapman V. Inhibitory effects of CB1 and CB2 agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur J Neurosci 2005, 22:371-379. 10.1111/j.1460-9568.2005.04206.x, 16045490.
71. Belvisi MG, Patel HJ, Freund-Michel V, Hele DJ, Crispino N, Birrell MA. Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways. Brit J Pharmacol 2008, 155:547-557.
72. Patel HJ, Birrel MA, Crispino M, Hele DJ, Venkatesan P, Barnes PJ, Yacoub M, Belvisi M. Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol 2003, 140:261-268. 10.1038/sj.bjp.0705435, 1574031, 12970104.
73. Jeske NA, Patwardhan AM, Gamper N, Price TJ, Akopian AN, Hargreaves KM. Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J Biol Chem 2006, 281(43):32879-32890. 10.1074/jbc.M603220200, 2910918, 16954222.
74. Gentry C, Stoakely N, Andersson DA, Bevan S. The roles of iPLA2, TRPM8 and TRPA1 in chemically induced cold hypersensitivity. Molecular Pain 2010, 6:4. 10.1186/1744-8069-6-4, 2822744, 20092626.
75. Karashima Y, Damann N, Prenen J, Talavera K, Segal A, Voets T, Nilius B. Bimodal action of menthol on the transient receptor potential channel TRPA1. J Neurosci 2007, 27(37):9874-9884. 10.1523/JNEUROSCI.2221-07.2007, 17855602.
76. Rohacs T, Lopes CMB, Michailidis I, Logothetis DE. PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nature Neuroscience 2005, 8(5):626-634. 10.1038/nn1451, 15852009.
77. Bottenstein JE, Sato GH. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 1979, 76(1):514-517. 10.1073/pnas.76.1.514, 382972, 284369.